Showing 181-190 of 328 grants
Title | Institution | Researcher | Program | Duration | Total Award Amount |
---|---|---|---|---|---|
Endothelial cells for islet replacement in diabetes | Stanford University | Martin Neukam | Cures | 01-April-2024 to 31-March-2027 | $251,600.00 |
A Magnetic Pumping Mechanism for Miniaturized High-Accuracy External Insulin Pump | Stanford University | Renee Zhao | Improving Lives | 01-May-2022 to 30-April-2025 | $676,000.00 |
Single-arm intervention trial of TWIIST™ AID DEKA Loop insulin pump in pregnant women with pre-existing type 1 diabetes | Stanford University | Tugce Akcan | Improving Lives | 01-March-2025 to 28-February-2027 | $180,600.00 |
Novel insulin formulations for pumps | Stanford University | Yanxian Zhang | Improving Lives | 01-March-2023 to 28-February-2026 | $243,986.00 |
Clinical Trial Recruitment | T1D Exchange, Inc. | Deborah Taylor | Transportfolio | 01-May-2023 to 30-April-2025 | $264,000.00 |
Research and Data Research | T1D Exchange, Inc. | Jaime Lucove | Transportfolio | 01-December-2022 to 30-November-2025 | $620,435.07 |
Implementing Best Practice Advisories to Reduce Inequities in Technology Use for people with Type 1 Diabetes | T1D Exchange, Inc. | Nicole Rioles | Improving Lives | 01-May-2024 to 30-April-2027 | $1,995,534.06 |
Novel Combination Regimen Therapy to Modulate Pro- and Anti-inflammatory Lipid Signaling to Counter T1D | The Board of Trustees of the University of Alabama for the University of Alabama at Birmingham | Sasanka Ramanadham | Cures | 01-July-2022 to 30-June-2025 | $600,000.00 |
Targeting Prostaglandin F-series Lipids to Counter Beta-Cell-Death and T1D Development | The Board of Trustees of the University of Alabama for the University of Alabama at Birmingham | Sasanka Ramanadham | Cures | 01-May-2023 to 30-April-2026 | $749,763.00 |
A prodrug system for targeted activation of small molecules in beta cells | The Brigham and Women’s Hospital, Inc. | Amit Choudhary | Cures | 01-February-2024 to 31-January-2027 | $2,250,000.00 |